Related Experiment Video
Updated: Jun 11, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
Comparative evaluation and selection of optimal QSAR-based machine learning model for liver toxicity prediction
Shreehari Thombre1, Chandrakant Bonde1, Prashant Kharkar2
1Department of Pharmaceutical Chemistry, SSR College of Pharmacy, Sayli Road, Union Territory of Dadra and Nagar Haveli, Silvassa, India.
This study developed a computational tool for predicting drug-induced liver toxicity. The model accurately identifies hepatotoxic compounds early, improving drug discovery efficiency and reducing costs.
Area of Science:
- Computational toxicology
- Medicinal chemistry
- Pharmacology
Background:
- Drug-induced liver toxicity is a major cause of acute liver failure.
- Current toxicity testing methods are costly, slow, and not scalable.
- Need for robust, interpretable computational tools for early hepatotoxicity prediction.
Purpose of the Study:
- To develop and validate a machine learning model for predicting drug-induced liver toxicity from molecular structure.
- To benchmark seven machine learning algorithms for hepatotoxicity prediction.
- To identify key structural features driving hepatotoxicity predictions.
Main Methods:
- Compiled a multi-source dataset of 6,219 compounds.
- Benchmarked seven machine learning algorithms using a unified preprocessing pipeline.
- Employed RDKIT for molecular feature calculation and Grid Search/Randomized Search for hyperparameter optimization.
- Utilized SHAP and LIME for model interpretability and applicability domain analysis.
Main Results:
- Achieved a test set ROC-AUC of 0.728, recall of 0.706, and F1-score of 0.700.
- External validation yielded an ROC-AUC of 0.741, demonstrating good generalization.
- Identified ECFP4 fingerprints and VSA-type descriptors as key predictors of hepatotoxicity.
- Model correctly identifies ~71% of hepatotoxic compounds before experimental testing.
Conclusions:
- Developed a reproducible, interpretable, and externally validated computational tool for early-stage hepatotoxicity screening.
- The model supports efficient and cost-effective prioritization of drug candidates.
- Identified structural features provide mechanistic insights into DILI mechanisms like lipophilic accumulation and CYP inhibition.
Related Concept Videos
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Toxicity Testing in Animals
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
